This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
WITH MORE than 40% of the world's cases of primary liver cancer, China is an appropriate site for international conferences on liver cancer. This year, Shanghai Medical University hosted the third Shanghai International Symposium on Liver Cancer and Hepatitis. The university has been holding these symposia every 5 years since 1986.More than 400 papers from around the world were presented at the conference, although the bulk were from researchers in China (Recent Progress in Liver Cancer and Hepatitis: Proceedings of 1996 Shanghai International Symposium on Liver Cancer and Hepatitis. Beijing, China: International Academic Publishers; 1996).Asked what was the most noticeable change between the second and third symposia, Sheng-Long Ye, MD, PhD, professor and vice chair of Shanghai Medical University's Liver Cancer Institute and coeditor of the symposium proceedings, said it was the dramatic increase of basic science that is now being applied to clinical research. Five
Skolnick AA. Basic Science Focus of Third International Symposium on Liver Cancer and Hepatitis. JAMA. 1996;276(18):1457-1458. doi:10.1001/jama.1996.03540180011004